Company Vineet Laboratories Limited

VINEETLAB

INE505Y01010

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 07:05:10 2026-06-25 am EDT			5-day change	1st Jan Change
34.00 ^INR	+0.18%		-1.93%	-7.56%

May. 29	Vineet Laboratories Limited Announces Resignation of Ramesh Kumar Bandari from Company Secretary and Compliance Officer and Ceases to Be Key Managerial Personnel, Effective May 29, 2026	CI
Feb. 14	Vineet Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI

Business description: Vineet Laboratories Limited

Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.

Number of employees: 57

Sales by Activity: Vineet Laboratories Limited

Fiscal Period: March	2021 (INR)	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)
Active Pharmaceuticals Ingredient and Intermediates	2.43B	1.91B	2.12B	1.51B	770M

See all business segments

Geographical breakdown of sales: Vineet Laboratories Limited

Fiscal Period: March	2021 (INR)	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)
India	2.42B	1.9B	2.03B	1.24B	750M
Unallocated	2.07M	8.53M	53.93M	33.97M	-
Export	8.73M	58K	35.86M	228M	-

See all geographic segments

Executive Committee: Vineet Laboratories Limited

Manager	Title	Age	Since
Venkata Ramana Gaddam CEO	Chief Executive Officer	56	2016-11-09
Satyanarayana Raju Bhupathiraju DFI	Director of Finance/CFO	76	2020-12-31
Pavani Srinivasa Rao HRO	Human Resources Officer	-	-
B V Ramakrishna AUD	Comptroller/Controller/Auditor	-	-

See VINEET LABORATORIES LIMITED governance

Composition of the Board of Directors: Vineet Laboratories Limited

Director	Title	Age	Since
Venkata Ramana Gaddam BRD	Director/Board Member	56	2016-11-09
Satyanarayana Raju Bhupathiraju BRD	Director/Board Member	76	2016-11-09
Alluri Ranga Raju BRD	Director/Board Member	52	-
Dilip Vishnu Acharekar CHM	Chairman	73	2020-11-15
Premananda Reddy Vennapusa BRD	Director/Board Member	-	2025-09-14
Jasmin Kunal Tailor BRD	Director/Board Member	-	2025-11-08

Composition of the Board of Directors

Company details: Vineet Laboratories Limited

Vineet Laboratories Ltd.

5-5-160, Malleswari Nilayam

500074, Hyderabad

+91 40 2412 8833

http://www.vineetlabs.co.in

address Vineet Laboratories Limited(VINEETLAB)

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VINEET LABORATORIES LIMITED	+0.18%	-1.93%	+11.11%	-32.27%	6.92M
ELI LILLY AND COMPANY	+7.13%	+9.97%	+51.94%	+166.83%	1,077B
JOHNSON & JOHNSON	+3.99%	+11.50%	+67.53%	+55.63%	613B
ABBVIE INC.	+4.20%	+17.03%	+35.63%	+87.74%	448B
ROCHE HOLDING AG	+0.99%	+4.85%	+27.93%	+22.82%	332B
ASTRAZENECA PLC	+1.82%	+8.19%	+41.15%	+26.80%	293B
NOVARTIS AG	+0.22%	+6.75%	+31.51%	+42.02%	286B
NOVO NORDISK A/S	+0.73%	+8.53%	-26.22%	-40.85%	215B
AMGEN INC.	+1.56%	+6.14%	+28.38%	+59.45%	193B
GILEAD SCIENCES, INC.	+3.26%	+3.33%	+18.83%	+67.03%	159B
Average	+1.88%	+6.89%	+28.78%	+45.52%	361.61B
Weighted average by Cap.	+2.26%	+8.93%	+40.51%	+81.28%